Hospital Clínic. Barcelona

Barcelona 08036

3 studies enrolling now · 6 studies all time

What they study most

Acute Respiratory Distress Syndrome, Autoimmune Encephalitis, Encephalitis, Infections, Liver Fibrosis, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Obesity, Pemphigus Vulgaris, Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Thymidine Kinase 2 Deficiency

Studies at this site

• Fibrosis Lessens After Metabolic Surgery — Recruiting now
• Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) — Recruiting now
• The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis — Recruiting now
• A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Completed
• A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency — Completed
• A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV) — Completed